CLINICAL_TRIALS
trial_result
· 2011-10-10
Clinical Trial Update: A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU) [Phase 3]
Summary
A Phase III study evaluating Diamyd in patients newly diagnosed with Type 1 diabetes in the EU was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Diamyd Therapeutics AB | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: TERMINATED